Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumours
Mulder, P.O.; Schröder, P.; de Vries-Hospers, H.G.; van der Geest, S.; Sleijfer, D.T.; Mulder, N.H.; de Vries, E.G.
Netherlands Journal of Medicine 34(3-4): 126-131
1989
ISSN/ISBN: 0300-2977 PMID: 2542817 Document Number: 339326
In a prospective study of 44 patients, who underwent autolgous bone marrow transplantation (ABMT) for solid tumours, the results of serial viral cultures and determination of complement-fixing antibodies to herpes simplex virus (HSV) were analysed. No primary infections with HSV occurred. Of 31 initially HSV-seropositive ABMT patients, 61% developed positive HSV cultures. Half of these patients showed a significant antibody rise. Active HSV infection did not influence the recovery of the bone marrow after ABMT, but coincided with a significantly increased number of febrile days.
Document emailed within 1 workday
Related Documents
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Engelhard, D.; Morag, A.; Or, R.; Naparstek, E.; Cividalli, G.; Ruchlemer, R.; Aker, M.; Maayan, S.; Slavin, S. 1988: Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts Israel Journal of Medical Sciences 24(3): 145-150
Contassot, E.; Ferrand, C.; Angonin, R.; Cohen, J.L.; de Carvalho Bittencourt, M.; Lorchel, F.; Laithier, V.; Cahn, J.Y.; Klatzmann, D.; Herve, P.; Tiberghien, P. 2000: Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting Transplantation 69(4): 503-508
Ohira, M.; Shibata, T.; Ise, T. 1983: Autologous bone marrow transplantation in solid tumors in children Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(6): 1428-1437
Schmitz, N.; Gratwohl, A.; Goldman, J.M. 1996: Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplantation 17(4): 471-477
Shiobara, S. 1990: Autologous bone marrow transplantation for solid tumors--indication and problems Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 2111-2116
Laufer, R.; Ben Bassat, Y.; Meytes, D. 1999: Autologous bone marrow transplantation in solid tumors in adults: hopes and disappointment Harefuah 137(9): 399-404
Novitzky, N.; Jacobs, P. 1982: Acyclovir therapy in cutaneous herpes simplex following bone marrow transplantation. A case report South African Medical Journal 62(8): 251-252
Tajima, T.; Tokuda, Y.; Yokoyama, S.; Mitomi, T.; Watanabe, K. 1990: Autologous bone marrow transplantation in the treatment of solid tumors: current status of clinical results Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 2134-2139
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Marinone, M.G.; Paganelli, C.; Ferremi, P.; Rossi, G.; Izzi, T. 1991: Aggressive ulcerous stomatitis due to the herpes simplex virus in an allogeneic bone marrow transplant. a clinical case Minerva Stomatologica 40(7-8): 499-503
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Tobian, A.A.R.; Charvat, B.; Ssempijja, V.; Kigozi, G.; Serwadda, D.; Makumbi, F.; Iga, B.; Laeyendecker, O.; Riedesel, M.; Oliver, A.; Chen, M.Z.; Reynolds, S.J.; Wawer, M.J.; Gray, R.H.; Quinn, T.C. 2009: Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda Journal of Infectious Diseases 199(7): 945-949
Mulder, P.O.; Sleijfer, D.T.; Willemse, P.H.; de Vries, E.G.; Uges, D.R.; Mulder, N.H. 1989: High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors Cancer Research 49(16): 4654-4658
Endo, M.; Tanosaki, R. 1995: Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(12): 1762-1770
Wang, Z.-y.; Wang, Z.-y.; Wen, H.-L.; Tao, Z.-x. 2005: ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 19(2): 159-161